Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

[Human rotavirus vaccine].

Taniguchi K.

Uirusu. 2012 Jun;62(1):87-96. Review. Japanese.

2.

Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe.

Plosker GL.

Drugs. 2010 Jun 18;70(9):1165-88. doi: 10.2165/11205030-000000000-00000. Review.

PMID:
20518582
3.

Rotavirus vaccines.

Vesikari T.

Scand J Infect Dis. 2008;40(9):691-5. Review.

PMID:
19086243
4.

Update on Rotarix: an oral human rotavirus vaccine.

O'Ryan M, Linhares AC.

Expert Rev Vaccines. 2009 Dec;8(12):1627-41. doi: 10.1586/erv.09.136. Review.

PMID:
19943758
5.

Characteristics of an ideal rotavirus vaccine.

Reisinger KS, Block SL.

Clin Pediatr (Phila). 2008 Jul;47(6):555-63. doi: 10.1177/0009922808314903. Epub 2008 May 8.

PMID:
18467670
6.

Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.

Ciarlet M, Schödel F.

Vaccine. 2009 Dec 30;27 Suppl 6:G72-81. doi: 10.1016/j.vaccine.2009.09.107. Review.

PMID:
20006144
7.

Prevention of childhood rotavirus disease through the use of Rotarix and RotaTeq vaccines.

Lepage P, Vergison A.

Expert Opin Biol Ther. 2007 Dec;7(12):1881-92. Review.

PMID:
18034653
8.

Clinical trials of rotavirus vaccines in Europe.

Vesikari T, Giaquinto C, Huppertz HI.

Pediatr Infect Dis J. 2006 Jan;25(1 Suppl):S42-7. Review.

PMID:
16397428
9.

[Rotavirus vaccine].

Ushijima H, Ishida S.

Nihon Rinsho. 2008 Oct;66(10):1977-83. Review. Japanese.

PMID:
18939500
10.

Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Cortese MM, Parashar UD; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2009 Feb 6;58(RR-2):1-25. Erratum in: MMWR Recomm Rep. 2010 Aug 27;59(33):1074.

11.

Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.

Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, López P, Macías-Parra M, Ortega-Barría E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavía-Ruz N, Salmerón J, Rüttimann R, Tinoco JC, Rubio P, Nuñez E, Guerrero ML, Yarzábal JP, Damaso S, Tornieporth N, Sáez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M; Human Rotavirus Vaccine Study Group.

N Engl J Med. 2006 Jan 5;354(1):11-22.

12.

Spotlight on pentavalent rotavirus vaccine (RotaTeq) in the prevention of rotavirus gastroenteritis in Europe.

Plosker GL.

BioDrugs. 2010 Dec 1;24(6):411-4. doi: 10.2165/11205070-000000000-00000.

PMID:
21043548
13.

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.

Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy and Safety Trial (REST) Study Team.

N Engl J Med. 2006 Jan 5;354(1):23-33.

14.

Rotavirus vaccines: an overview.

Dennehy PH.

Clin Microbiol Rev. 2008 Jan;21(1):198-208. doi: 10.1128/CMR.00029-07. Review.

15.

RotaTeq: a new oral rotavirus vaccine.

[No authors listed]

Med Lett Drugs Ther. 2006 Jul 31;48(1240):61-3. No abstract available.

PMID:
16874281
16.

[Rotavirus Vaccine. Statement of the Consultive Committee of Immunizations on behalf of The Chilean Infectious Diseases Society. March 2006].

Muñoz M A, Abarca V K, Luchsinger F V, Valenzuela B MT, Jiménez de la J J; Comité Consultivo de Inmunizaciones, Sociedad Chilena de Infectología.

Rev Chilena Infectol. 2006 Jun;23(2):124-7. Epub 2006 May 16. Review. Spanish.

17.

A live attenuated human rotavirus vaccine.

Bernstein DI.

Drugs Today (Barc). 2007 May;43(5):281-91. Review.

PMID:
17724495
18.

Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study.

Phua KB, Lim FS, Lau YL, Nelson EA, Huang LM, Quak SH, Lee BW, Teoh YL, Tang H, Boudville I, Oostvogels LC, Suryakiran PV, Smolenov IV, Han HH, Bock HL.

Vaccine. 2009 Oct 9;27(43):5936-41. doi: 10.1016/j.vaccine.2009.07.098. Epub 2009 Aug 11.

PMID:
19679216
19.

Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Parashar UD, Alexander JP, Glass RI; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2006 Aug 11;55(RR-12):1-13.

20.

Real-time RT-PCR assays to differentiate wild-type group A rotavirus strains from Rotarix(®) and RotaTeq(®) vaccine strains in stool samples.

Gautam R, Esona MD, Mijatovic-Rustempasic S, Ian Tam K, Gentsch JR, Bowen MD.

Hum Vaccin Immunother. 2014;10(3):767-77. Epub 2013 Dec 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk